Introduction
Cell therapy using stem cells is awaited by stroke patients with impaired movement and cognitive functions.
Middle cerebral artery occlusion (MCAO) induces a massive unilateral loss of neuron, and it causes behavioral dysfunction in rats 1 . It is well known that the degree of disability does not simply reflect the severity or distribution of the impaired blood supply, and populations of adjacent cells in the brain can display dramatically different vulnerabilities to equivalent degrees of ischemia. The continued expansion of ischemic infarction is not caused directly by the reduction in local blood flow, but by secondary processes 2 . The proper process of functional recovery in stroke patients being the main issue, this gradual enlargement of infarction can be limited by a variety of interventions that do not interfere with cerebral blood flow. Therefore, we performed an analysis to investigate the evolution of infarct after MCAO.
We performed this analysis in rats, a model system that has been .
Thus, the priming strategy tested in stem cell transplantation after brain ischemia may represent a clinically feasible manipulation of cell preparation for more effective transplantation therapy.
Methods

Experimental design
Twenty four transient ischemic middle cerebral artery occlusion (MCAO) rat models were prepared. After the MCAO procedures, all of the rats were randomly assigned to one of two groups (n=24): infarct with PBS-only injection (group A, n=10), infarct with mESC transplantation (group B, n=14).
Mouse embryonic stem cell culture
ES cell cultures were prepared from stocks of an EK1 cell line (TC-1 derived from 129S6) maintained in our laboratory. Not more than 40 passages were used for experiments. The passage procedure of undifferentiated ES cells was performed every 2 days on gelatin-coated T25 flasks in the presence of 1000 U/ml of leukemia inhibitory factor from Chemicon International (LIF) (LIF2010, Temecula, CA) and high-glucose dulbecco's Modified
Eagle's Medium (DMEM) (GibcoBRL, Germany) with 15% FBS (Hyclone), 0.1 mM mercaptoethanol, 1 uM sodium pyruvate, 1x
non-essential amino acids and 1 mM L-glutamine (GibcoBRL).
Briefly, ES cells were harvested from T25 flasks by trypsinization with 0.25% trypsin and placed into a standard 100-mm bacterial
Petri dish in ESIM without adding LIF or β-mercaptoethanol.
Medium was removed and cells were resuspended in modified Sato medium. Cells were then plated on poly-D-lysine (PDL) and laminin coated 35-mm glassbottom dishes for imaging studies or 24-well plates in preparation for serum deprivation (SD) experiments.
Middle cerebral artery occlusion model
The rat MCAO model was used as a stroke model.
This study was approved by the animal care and use committee of Namseoul University, and all procedures were carried out in accordance with institutional guidelines. We induced permanent MCAO by using a previously described method of intraluminal vascular occlusion. 11 Adult male Sprague-Dawley rats (n=24)
weighing 250-300g were anesthetized with an intrapenitoneal (i.p.) injection of ketamine (75 mg/kg) and xylazine (10 mg/ kg). We induced transient left middle cerebral artery occlusion (MCAo) for 90 min as previously described [10] [11] . Briefly, a 4-0 nylon monofilament coated with silicone was inserted from the left common carotid artery (CCA) via the internal carotid artery to the base of the left MCA. After the occlusion for 20 minutes, the filament was withdrawn.
Cell transplantation and TTC staining
The rats received one injection of mES cells along the anterior-posterior axis of the ipsilateral cortex targeting to the striatum by using a predetermined stereotactic frame (David Kopf Instrument, Tujunga, CA, USA) three hours after MCAO.
After anesthesia with an intraperitoneal injection of ketamine hydrochloride (90 mg/kg) or urethane anesthetized (1.5g/kg, 30% aqueous solution, ip), the rats were given 25.0 μl deposits of suspended cells (3 x 10 5 cells per μl) along the anteriorposterior axis into the target brain at these coordinates: from the bregma, 1.5 mm laterally and to 3 mm depth. The deposits were delivered by an infusion pump at 0.5 μl/min. Cells were injected while withdrawing the pipette in 100 μm increments. A 2 min waiting period at the end of injection allowed the ES cells to settle before needle removal (the total procedure needed about 50 min).
To suppress rejection of mouse ES cells, rat hosts of the ESC transplanted group were administered cyclosporine A (15 mg/kg/ day s.c.; Sandoz Pharmaceutical Corp. NJ) diluted in extra virgin oil, starting with a double-dose 1 day before surgery. Ten days after transplantation, the dosage was reduced to 10 mg/kg/day until the day before sacrifice. Rats were euthanized at 15 days of reperfusion. The brains were chilled at −80ºC for 4min to slightly harden the tissue. Five, 2-mm coronal sections were made from the olfactory bulb to the cerebellum and then stained with 1.5% TTC (Sigma, St. Louise, MO). The stained brain sections were captured with Magnifier digital camera.
GFP-gene transfection to mouse ESCs with vector
GFP was transferred for the labeling of transplanted cells using chicken actin-pEGFP-1 vector. Mouse ESCs were exposed to the infectious viral particles in 40 ml of the culture media at 
Statistical analysis
Quantitative data were expressed as mean ± SEM. Twoway ANOVA and Student's t test with the Bonferroni correction for multiple pair-wise comparisons were used for statistical analysis.
p values <0.05 were considered significant.
Results
Morphological characteristics of mESC
Primary mESCs cultured as plastic adherent cells could be maintained in culture. Figure 1 shows the morphological features of these cells. Characteristic doom like-shaped cells can be recognized. The in vitro neural differentiation from mouse ES to ES-N cells was performed as described previously. 
Cell survival and Identification of donor cells in vivo
In the model of focal cerebral ischemia that we employed, which involves occlusion of the MCA at its origin, the striatum is the site of the most pronounced ischemic damage and neuronal loss. Therefore, the first approach we undertook was to transplant cultured neural precursor cells directly into the ischemic region of the rat striatum (Figure 3 ). This was done 24h after the onset of ischemia, and rats were killed 15 days later. After focal ischemia, however, transplanted cells survived and migrated into the ischemic striatum (Figure 3) . The surviving cells of transplanted GFP-positive mESC were mainly resided in the transplanted site in all rats receiving mESCs. The transplanted cells tended to correlate to infarct volumes in each rat. 
Motor behavioral index
In order to explore functional benefits of the transplanted mES cells, we assessed neurological and behavioral activities up to 15 days after transplantation. Neurological severity scores (NSS)
were calculated based on a series of motor, sensory, reflex, and balance tests 12 between control and cell-transplanted, respectively.
During 15 days after transplantation, rats that received PBS show a little behavioral improvement, while transplantation of mESCtransplanted already displayed an early beneficial effect on NSS function and performed significantly better than the control group ( Figure 4A , B, C). Thus, cell-transplanted group conferred accelerated recovery in a number of sensorimotor activities. By 15 days after transplantation, group that received mESCs performed significantly better compared to control rats. To assess the motor function more specifically, animals were trained on the rotarod three days prior to ischemic insult (five days before transplantation).
Transplantation of mESC improved motor function on the rotarod test 15 days after transplantation. Behavioral activities longer than 15 days after transplantation were not tested in this investigation. FIGURE 4A -Motor functions were examined between control group and mESC-transplanted group. Cell transplantation enhanced motor ability after ischemia. Scores were compared to baseline data generated before stroke and are represented as % of control. P<0.05 compared with PBS (n=10) only; P<0.05 compared with cell transplanted group (n=14).
FIGURE 4B -Somatosensory function was examined between control group and mESC-transplanted group. Improved somatosensory function was shown in transplanted group. P<0.05 compared with PBS (n=10) only; P<0.05 compared with cell transplanted group (n=14).
FIGURE 4C
-Neurological dysfunctions were examined between control group and mESC-transplanted group. Impaired neurological behaviors were significantly recovered in transplanted group. P<0.05 compared with PBS (n=10) only; P<0.05 compared with cell transplanted group (n=14).
Discussion
The present study revealed several findings that are important for investigators that utilize murine models of stroke.
Firstly, the transient MCAO model, which is widely used in stroke research, induces a peak volume of injury as delineated by TTC staining by 24h and remains unchanged through day 7 of reperfusion. A spatiotemporal evolution of core and penumbra was also seen 6 ; at earlier time points the histological infarct core, as measured by TTC is in the striatum, and the viable tissue was around this core, and included the cortex. Subsequently the TTC- Further study may prove that, in addition to ischemic stroke, the strategy is applicable to cell therapies for other CNS and non-CNS disorders.
Conclusion
The mouse embryonic stem cells may have advantage for use as a donor source in various neurological disorders including motor dysfunction.
